Contraceptive Pills Market Outlook
According to a recent report by Expert Market Research, the global contraceptive pills market size is expected to grow from USD 18.66 billion in 2021 to USD 26.35 billion by 2031, growing at a CAGR of 3.92% during the forecast period of 2023-2031. The market is dominated by the North America and Europe regions, owing to the high awareness about contraception and family planning in these regions.
The global contraceptive pills market is expected to grow at a significant rate over the forecast period of 2023-2031. Contraceptive pills are a type of hormonal contraceptive used to prevent pregnancy by inhibiting ovulation or thickening cervical mucus. The market is driven by factors such as the increasing awareness about contraception and family planning, rising population growth, and increasing adoption of modern contraceptive methods.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/contraceptive-pills-market/requestsample
Price Trends
The price of contraceptive pills varies depending on the brand and type of pill. In the United States, the average retail price of a one-month supply of combination pills ranges from $20 to $50, while the average retail price of a one-month supply of progestin-only pills ranges from $35 to $50.
Market Trends
The market is driven by several trends, including:
Increasing awareness about contraception and family planning: The increasing awareness about contraception and family planning is leading to the increased adoption of modern contraceptive methods, such as contraceptive pills.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/contraceptive-pills-market
Rising population growth: The increasing population growth is leading to increased demand for family planning and contraception.
Increasing adoption of modern contraceptive methods: The increasing adoption of modern contraceptive methods, such as contraceptive pills, is driving the growth of the market.
Technological advancements: There have been significant advancements in the development of contraceptive pills, such as the introduction of low-dose pills and extended-cycle pills. These advancements have led to increased effectiveness and convenience.
Government initiatives: Governments around the world are introducing initiatives to promote family planning and contraception, which is driving the demand for contraceptive pills.
Market Analysis
The global contraceptive pills market is segmented based on type, category, distribution channel, and region.
Based on type, the market is segmented into combination pills and progestin-only pills. Combination pills are the largest segment of the market, owing to their high effectiveness and ease of use.
Based on category, the market is segmented into branded and generic. The generic segment is expected to witness faster growth during the forecast period, owing to the lower cost of generic pills compared to branded pills.
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies are the largest segment of the market, owing to the easy availability of contraceptive pills at these stores.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America and Europe are the largest markets for contraceptive pills, owing to the high awareness about contraception and family planning in these regions. The Asia Pacific region is expected to witness the fastest growth during the forecast period, owing to the increasing population growth and government initiatives to promote family planning.
Competitive Landscape
The global contraceptive pills market is highly competitive, with several players competing based on price, quality, and product differentiation. Some of the key players in the market include:
- Pfizer Inc.
- Merck & Co., Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Lupin Limited
- Novartis AG
- Mankind Pharma Ltd.
- Sun Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.
These companies are investing in research and development to develop new and innovative contraceptive pills, as well as expanding their geographic presence through partnerships and acquisitions.
Conclusion
The global contraceptive pills market is expected to grow at a significant rate over the forecast period of 2023-2028, driven by factors such as the increasing awareness about contraception and family planning, rising population growth, and increasing adoption of modern contraceptive methods. The market is dominated by North America and Europe, while the Asia Pacific region is expected to witness the fastest growth during the forecast period. The market is highly competitive, with several key players competing based on price, quality, and product differentiation. The market is segmented based on type, category, distribution channel, and region. Combination pills are the largest segment of the market, while retail pharmacies are the largest distribution channel. The market is expected to witness significant growth during the forecast period, owing to the increasing demand for modern contraceptive methods and government initiatives to promote family planning and contraception.
FAQs:
Q: What is the expected market size of the contraceptive pills market in 2023-2028?
A: The global contraceptive pills market size is expected to grow from USD 15.5 billion in 2021 to USD 20.55 billion by 2028, growing at a CAGR of 8.8% during the forecast period.
Q: What are contraceptive pills used for?
A: Contraceptive pills are a type of hormonal contraceptive used to prevent pregnancy by inhibiting ovulation or thickening cervical mucus.
Q: What are the factors driving the growth of the contraceptive pills market?
A: The growth of the contraceptive pills market is driven by factors such as the increasing awareness about contraception and family planning, rising population growth, and increasing adoption of modern contraceptive methods.
Q: What are the types of contraceptive pills?
A: The market is segmented into combination pills and progestin-only pills.
Q: What is the difference between combination pills and progestin-only pills?
A: Combination pills contain both estrogen and progestin hormones, which work together to prevent ovulation. Progestin-only pills, also known as mini-pills, contain only progestin hormone and are used by women who cannot take estrogen.
Q: What is the expected growth rate of the Asia Pacific region in the contraceptive pills market?
A: The Asia Pacific region is expected to witness the fastest growth during the forecast period, owing to the increasing population growth and government initiatives to promote family planning.
Q: Which regions are the largest markets for contraceptive pills?
A: North America and Europe are the largest markets for contraceptive pills, owing to the high awareness about contraception and family planning in these regions.
Q: What are some key players in the contraceptive pills market?
A: Some of the key players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., and Mylan N.V.
Q: How is the market segmented based on end user?
A: The market is segmented into hospitals, clinics, and homecare.
Q: What are some technological advancements in the development of contraceptive pills?
A: There have been significant advancements in the development of contraceptive pills, such as the introduction of low-dose pills and extended-cycle pills. These advancements have led to increased effectiveness and convenience.
Media Contact:
Company Name: Claight Corporation
Contact Person: Jhon Roy, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
